We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Visual Ordinal CAC Assessment on Chest CT Found to Have High Diagnostic Performance

By HospiMedica International staff writers
Posted on 28 Apr 2022

Current guidelines recommend visual evaluation of coronary artery calcium (CAC) on all non-gated non-contrast chest CT examinations. More...

However, chest CT examinations are often performed with contrast material administration. Now, a new study has found that visual ordinal CAC assessment on both contrast-enhanced and non-contrast chest CT has high diagnostic performance, prognostic utility, and interobserver agreement.

The retrospective study conducted by researchers from Toronto General Hospital, University Health Network (Toronto, ON, Canada) included 260 patients (mean age, 60; 158 male, 102 female) who underwent both non-gated chest CT (contrast-enhanced in 116 patients; non-contrast in 144 patients) and cardiac calcium-score CT within a 12-month interval. A cardiothoracic radiologist visually assessed CAC on chest CT using an ordinal scale: absent, mild, moderate, or severe. Cardiac CT Agatston calcium scores were quantified according to established guidelines and categorized as absent (0), mild (1-99), moderate (100-299), or severe (≥300). Diagnostic performance of chest CT for presence of CAC was assessed using cardiac CT as reference standard. Major adverse cardiac events (MACE) were assessed as a composite of cardiovascular death and myocardial infarction and evaluated using Cox proportional hazards models. A second cardiothoracic radiologist performed visual CAC assessments in a random subset of 50 chest CT examinations to assess interobserver agreement.

The findings revealed that for the presence of any CAC on cardiac CT, contrast-enhanced and non-contrast chest CT had sensitivity of 83% and 90% and specificity of 100% and 100%. CAC present on cardiac CT was misclassified as absent on 13 contrast-enhanced and 10 non-contrast chest CT examinations; Agatston score was less than 30 in all such patients, and none experienced MACE. Visual ordinal CAC score was associated with MACE for contrast-enhanced [hazard ratio (HR)=4.5 [95% CI 1.2, 16.4], p=.02) and non-contrast (HR=3.4 [95% CI 1.5, 7.8], p=.003) chest CT. Interobserver agreement was excellent for contrast-enhanced (κ =0.95) and non-contrast (κ =0.89) chest CT.

“Visual ordinal CAC assessment on both contrast-enhanced and non-contrast chest CT has high diagnostic performance, prognostic utility, and interobserver agreement,” confirmed corresponding author Kate Hanneman, MD, MPH, from Toronto General Hospital, University Health Network in Ontario. “Routine reporting of CAC on all chest CT examinations regardless of clinical indication and contrast material administration could identify a large number of patients with previously unknown CAC who might benefit from preventive treatment.”

Related Links:
University Health Network 


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Monitor/Defibrillator
Zenix
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: FDA clearance of multiFiltratePRO and approval of dedicated solutions expand continuous kidney replacement therapy options for U.S. patients with acute kidney injury. (Photo courtesy of Fresenius Medical Care)

U.S. Launch Expands Kidney Replacement Therapy Options With Integrated Anticoagulation

Critically ill patients with acute kidney injury often require continuous kidney replacement therapy in intensive care units. During these extracorporeal treatments, careful anticoagulation management... Read more

Surgical Techniques

view channel
Image: The LUCID prototype, which combines a miniature ultrasound device with a fluid-delivery tube, an osmotic pump and custom electronics. A coin provides a sense of scale. The system is designed to deliver substances directly into brain tissue and uses ultrasound to help them spread. (Photo courtesy of MIT)

Implantable Ultrasound Device Enhances Local Drug Delivery in Glioblastoma

Glioblastoma is an aggressive brain tumor that frequently recurs after surgery. Although surgeons can remove visible tumor tissue, residual cancer cells may remain in surrounding brain tissue and contribute... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.